SBIR/STTR Research Award

WHICH ISOTYPE OF ECD4-IG MOST EFFECTIVELY SUPPRESSES VIRUS REPLICATION?

Award identifier fdcc2db44c2567e40f4b5b2c3a6f8f39204649c4e1e4da45be4725e93afb2b06Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$1,235,438

Program and phase

SBIR · Phase I

Award year

2016

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
EMMUNE INC
Proposal award date
2016-06-10
Contract end date
2016-11-30
UEI
N65ZDYUGWAH8
Solicitation number
PA15-269
Topic code
NIAID

Research abstract

DESCRIPTION provided by applicant We have engineered a synthetic antibody that neutralizes of HIV strains This antibody is built from the parts of CD and CCR that are recognized by HIV and is named andquot eCD Ig andquot The goal of our research program is now to maximize its efficacy A fundamental question for our effort and for the field as a whole is Which isotype of IgG has the properties that are most important for suppressing viral replication To answer this question we will eliminate problematic features of IgG and IgG that have historically presented a barrier to their use as therapeutics in humans and we will compare the ability of rhesus IgG IgG and IgG forms of eCD Ig to suppress SIV replication in macaques The isotype of eCD Ig that most completely suppresses viral replication will be advanced to human clinical trials PUBLIC HEALTH RELEVANCE The HIV pandemic continues to be a catastrophe for global health We are developing approaches based on a synthetic antibody named andquot eCD Ig andquot for treating and preventing HIV infection The proposed project will resolve a fundamental scientific question about how to most effectively treat or prevent HIV infection and indicate which is the best embodiment of eCD Ig to advance to human clinical trials

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

17 SBIR/STTR records share this UEI (2015–2025). Reported award amounts total $20,456,694. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.